Literature DB >> 24359057

Severe adenomyosis and CA125.

S S Sheth1, S S Ray.   

Abstract

A total of 50 women having uterine enlargement of > 12 weeks' size due to severe adenomyosis with raised CA125, were carefully studied and compared with other cases. The greater the enlargement of the uterus over 240 cm(3) volume or 12 weeks' uterine size due to severe adenomyosis, the greater was the rise of CA125 levels and these were disturbingly high in some cases. However, similarly enlarged uteri due to fibroids did not show a rise in CA125 levels above normal. Raised CA125 thus need not instil anxiety, when the clinical findings are benign.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24359057     DOI: 10.3109/01443615.2013.832178

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  8 in total

1.  Severe adenomyosis with unexpectedly high CA-125: report of a rare case.

Authors:  Ibrahim A Abdelazim; Mohannad AbuFaza; Mohamed E S Hamed; Yerbol Bekmukhambetov; Gulmira Zhurabekova; Svetlana Shikanova
Journal:  Prz Menopauzalny       Date:  2020-10-02

2.  Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis.

Authors:  Rui Zheng; Dan Zeng; Ting-Ting Wan; Wen-Bo Guo; Yan Guo; Ming-Juan Liu
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

3.  Ultrasound-guided percutaneous microwave ablation for adenomyosis: efficacy of treatment and effect on ovarian function.

Authors:  Yu Yang; Jing Zhang; Zhi-yu Han; Xia Ma; Yan-li Hao; Chang-tao Xu; Rui-fang Xu; Bing-song Zhang
Journal:  Sci Rep       Date:  2015-05-05       Impact factor: 4.379

4.  How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis.

Authors:  Marco Aurelio Pinho Oliveira; Thiers Soares Raymundo; Leila Cristina Soares; Thiago Rodrigues Dantas Pereira; Alessandra Viviane Evangelista Demôro
Journal:  Biomed Res Int       Date:  2017-06-04       Impact factor: 3.411

5.  Systemic thromboembolism including multiple cerebral infarctions with middle cerebral artery occlusion caused by the progression of adenomyosis with benign gynecological tumor: a case report.

Authors:  Ryo Aiura; Sadayoshi Nakayama; Hroo Yamaga; Yu Kato; Hirotake Fujishima
Journal:  BMC Neurol       Date:  2021-01-11       Impact factor: 2.474

6.  Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis.

Authors:  Ling Huang; Yubin Li; Minghui Chen; Zengyan Wang; Canquan Zhou
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

7.  Drug therapy for adenomyosis: a prospective, nonrandomized, parallel-controlled study.

Authors:  Qing Li; Yan Ding; Xu-Yin Zhang; Wei-Wei Feng; Ke-Qin Hua
Journal:  J Int Med Res       Date:  2018-03-19       Impact factor: 1.671

8.  Evaluation of adenomyosis after gonadotrophin-releasing hormone agonist therapy using ultrasound post-processing imaging: a pilot study.

Authors:  Szu-Yuan Chou; Cindy Chan; Yu-Chieh Lee; Tzu-Ning Yu; Chii-Ruey Tzeng; Chi-Huang Chen
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.